3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
5
Colitis
4
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Vasculitis
1
Stroke
1
Skin Neoplasms
1
Lung Neoplasms
1
Kidney Transplantation
1
Hepatitis
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Drug-Related Side Effects and Adverse Reactions
1
Depressive Disorder, Treatment-Resistant
1
Depressive Disorder, Major
1
Depression
1
Colitis, Ulcerative
1
Bronchiolitis Obliterans Syndrome
1
Bipolar Disorder
1
Aneurysm
1
Interventions
epigallocatechin gallate
2
Ascorbic Acid
2
semaglutide
1
microcrystalline cellulose
1
dapagliflozin
1
cytisine
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
XENP 1595
1
Vitamin D
1
Topiramate
1
Tirzepatide
1
Spirometry
1
Selenium
1
Saline Solution
1
Resistance Training
1
Reperfusion
1
Qsymia
1
Probiotics
1
Platelet Count
1
Plastic Surgery Procedures
1
Phentermine
1
Naltrexone
1
Losartan
1
Liraglutide
1
Ischemic Preconditioning
1
Hematologic Tests
1
Glucagon-Like Peptide-1 Receptor
1
Endurance Training
1
Diethylpropion
1
Diet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Inflammation
×
Infliximab
×
1 year
×
Clear all
No trials found.